MZ-001

N/A

Report date: 2022/09/22 11:01:42
NME

Base Information

Drug NameMZ-001
Drug Alias NameMZ-001
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionTyrosine-protein kinase BTK modulatorsProteolysis
TargetsTyrosine-protein kinase BTKBTK C481S
Therapy Area/IndicationsAutoimmune DiseasesLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Meizer Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Meizer Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A